SCHEMBL10246213

SCHEMBL10246213

COc1cc(C)c(S(=O)(=O)N(CCO)Cc2cnc3ccccc3c2)c(C)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HIF1A Q16665 1/20 0.47
EPAS1 Q99814 1/20 0.47
ALDH1A1 P00352 3/20 0.42
HPGD P15428 1/20 0.42
TRPM8 Q7Z2W7 2/20 0.41
FAAH O00519 2/20 0.40
PDE10A Q9Y233 4/20 0.40
PTGES O14684 1/20 0.40
ALOX5 P09917 1/20 0.40
ALPL P05186 4/20 0.39
LMNA P02545 2/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
KDM4E B2RXH2 1/20 0.38
TSHR P16473 1/20 0.38
HDAC3 O15379 1/20 0.38
HDAC4 P56524 1/20 0.38
HDAC1 Q13547 1/20 0.38
HDAC7 Q8WUI4 1/20 0.38
HDAC2 Q92769 1/20 0.38
HDAC10 Q969S8 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10246085 0.86 HIF1A (0.46) HIF1AEPAS1ALDH1A1TRPM8FAAH
SCHEMBL701618 0.86 HIF1A (0.44) HIF1AEPAS1TRPM8FAAHPDE10A
SCHEMBL4091783 0.83 TAS2R14 (0.48) ALDH1A1HPGDPTGESKDM4ETSHR
SCHEMBL10246224 0.83 HIF1A (0.40) HIF1AEPAS1TRPM8FAAHPTGES
SCHEMBL13660782 0.79 PDE4A (0.48) ALDH1A1LMNAKDM4E
SCHEMBL12340031 0.73 BDKRB1 (0.38) ALDH1A1HPGDLMNAKDM4EFGFR1
SCHEMBL3995079 0.73 BDKRB1 (0.43) ALDH1A1SMN1; SMN2TSHR
SCHEMBL6273675 0.72 SMN1; SMN2 (0.42) ALDH1A1LMNASMN1; SMN2KDM4E
SCHEMBL10246053 0.71 TSHR (0.47) ALDH1A1LMNATSHR
SCHEMBL4095611 0.69 AVPR1B (0.48) ALDH1A1HPGDKDM4ETSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8124624-B2 Substituted sulfonamide compounds GRUENENTHAL GMBH (DE) 2012-02-28 US disclosed
US-8124624-B2 Substituted sulfonamide compounds GRUENENTHAL GMBH (DE) 2012-02-28 US disclosed
US-20090264407-A1 Substituted Sulfonamide Compounds GRUENENTHAL GMBH (DE) 2009-10-22 US disclosed
US-20090264407-A1 Substituted Sulfonamide Compounds GRUENENTHAL GMBH (DE) 2009-10-22 US disclosed
WO-2009124734-A2 SUBSTITUTED SULFONAMIDE DERIVATIVES Grünenthal GmbH (DE) 2009-10-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090264407-A1 Substituted Sulfonamide Compounds CNR1, SUCNR1, OPRL1 HIF1A 630/4885EPAS1 786/4885ALDH1A1 958/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.